1. Home
  2. SPTX vs EQBK Comparison

SPTX vs EQBK Comparison

Compare SPTX & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$18.60

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo Equity Bancshares Inc.

EQBK

Equity Bancshares Inc.

N/A

Current Price

$47.07

Market Cap

1.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SPTX
EQBK
Founded
2024
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
SPTX
EQBK
Price
$18.60
$47.07
Analyst Decision
Strong Buy
Buy
Analyst Count
8
7
Target Price
$38.29
★ $56.86
AVG Volume (30 Days)
★ 155.6K
71.1K
Earning Date
11-05-2026
10-13-2026
Dividend Yield
N/A
★ 1.87%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 2.06
Revenue
N/A
N/A
Revenue This Year
N/A
$30.59
Revenue Next Year
N/A
$21.34
P/E Ratio
★ N/A
$23.01
Revenue Growth
N/A
N/A
52 Week Low
$17.59
$38.60
52 Week High
$28.38
$52.27

Technical Indicators

Market Signals
Indicator
SPTX
EQBK
Relative Strength Index (RSI) 44.86 31.36
Support Level $18.72 $47.02
Resistance Level $22.75 $48.80
Average True Range (ATR) 1.81 0.97
MACD -0.26 -0.19
Stochastic Oscillator 32.71 11.08

Price Performance

Historical Comparison
SPTX
EQBK

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

Share on Social Networks: